Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ANI Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIP
Nasdaq
2834
https://www.anipharmaceuticals.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ANI Pharmaceuticals Inc
New Strong Sell Stocks for March 13th
- Mar 13th, 2023 11:06 am
Q4 2022 ANI Pharmaceuticals Inc Earnings Call
- Mar 10th, 2023 4:45 am
ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Top Estimates
- Mar 9th, 2023 1:05 pm
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
- Mar 9th, 2023 11:50 am
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: Should You Buy?
- Mar 2nd, 2023 3:00 pm
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
- Mar 1st, 2023 9:16 pm
Mirati (MRTX) Reports Q4 Loss, Misses Revenue Estimates
- Feb 28th, 2023 10:35 pm
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET
- Feb 22nd, 2023 9:05 pm
Bullish ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) insiders filled their treasuries with US$752k worth of stock over last year
- Feb 7th, 2023 11:39 am
The past five years for ANI Pharmaceuticals (NASDAQ:ANIP) investors has not been profitable
- Dec 22nd, 2022 12:19 pm
ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP
- Dec 19th, 2022 9:56 pm
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
- Nov 28th, 2022 11:50 am
This Biopharma 'Fits the Bill' as a Growth Play
- Nov 27th, 2022 2:31 pm
ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
- Nov 16th, 2022 11:50 am
ANI Pharmaceuticals Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
- Nov 11th, 2022 10:25 am
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
- Nov 9th, 2022 1:05 pm
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
- Nov 9th, 2022 11:50 am
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
- Oct 24th, 2022 10:50 am
ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer
- Sep 12th, 2022 10:50 am
Bullish ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) insiders filled their treasuries with US$1.0m worth of stock over last year
- Aug 31st, 2022 10:59 am
Scroll